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Available online 18 March 2017Sertoli cells are crucial for the success of spermatogenesis, which is the biological process that ensures male fer-
tility. These cells present highmetabolic rates, being often subjected to high oxidative stress levels that, if uncon-
trolled,may compromisemale fertility. Since themost abundant tea catechin, epigallocatechin-3-gallate (EGCG),
has demonstrated a potent preventive activity against oxidative stress, we have evaluated its effect at concentra-
tions of 5 and 50 μM, on the metabolism, mitochondrial functionality and oxidative profile of human Sertoli cells
(hSCs). While, the highest concentration of EGCG (50 μM) increased glucose and pyruvate consumption, it de-
creased the conversion of pyruvate to alanine to sustain a regular lactate production. However, despitemaintain-
ing Krebs cycle functionality, EGCG (50 μM) decreased mitochondrial membrane potential of hSCs, which could
compromise the normal rates of ATP production. Interestingly, oxidative damages to proteins and lipids de-
creased in this experimental group, which may be valuable for the nutritional support of spermatogenesis.







Tea is one of the most widely consumed beverages worldwide. Al-
though it is commonly drunk for pleasure, tea is well-known for its
health-promoting properties. The main constituents of tea leaves in-
clude proteins, polyphenols, methylxanthines, amino and organic
acids (Dias et al., 2014c). Epigallocatechin-3-gallate (EGCG) is the
most abundant and biologically active tea polyphenol, representing
50–80% of the total tea catechins (Khan and Mukhtar, 2007). Most of
the tea's medicinal properties are attributed to EGCG, which has dem-
onstrated a potent preventive activity against oxidative stress (OS)lectron transport chain;GLUT1,
3, glucose transporter 3; GLUTs,
lactate dehydrogenase; MCT4,
stress; OXPHOS, oxidative
reactive oxygen species; SCs,
arch Centre, University of Beira
ortugal.
icroscopy, Laboratory of Cell
(ICBAS), Rua de Jorge Viterbo
gmail.com (P.F. Oliveira).(Lombardo et al., 2011). Its ability to protect cells from reactive oxygen
species (ROS)-induced damages has made EGCG a popular nutraceuti-
cal. Tea and its constituents are currently receiving considerable atten-
tion since they can be used as dietary supplements to prevent or even
treat several diseases/dysfunctions. For instance, they have been de-
scribed as potential modulators of spermatogenesis (Dias et al.,
2014a), which is the process of sperm production. Sertoli cells (SCs)
are the testicular cells responsible for themaintenance of spermatogen-
esis. The resulting metabolites of the distinctive metabolism of these
cells are essential for the survival of developing germ cells. Particularly,
the lactate produced by SCs constitutes the preferred substrate of germ
cells for energy production (Dias et al., 2014b).When the metabolic co-
operation between SCs and germ cells is disrupted, fertility problems
may arise (Alves et al., 2014). The increasing incidence of male
subfertility/infertility highlighted the need for new therapies. Interest-
ingly, the consumption of tea seems to be a promising approach (Dias
et al., 2016b; Oliveira et al., 2015b). However, the underlying mecha-
nisms remain unknown. We have previously demonstrated that a
white tea extract was able to alter rat SCsmetabolism, suggesting possi-
ble implications formale fertility (Martins et al., 2014). Additionally, the
exposure of human SCs (hSCs) to themost abundantmethylxanthine of
tea, caffeine, led to increased production of lactate and alanine, affecting
215T.R. Dias et al. / Toxicology in Vitro 41 (2017) 214–222cells oxidative profile (Dias et al., 2015b). Tough, there is a lack of infor-
mation concerning the effect of catechins on these testicular cells. Here-
in, we aimed to evaluate the effect of EGCG (5 and 50 μM) on hSCs
metabolism, mitochondrial functionality and oxidative profile. We hy-
pothesize that EGCG can act as a relevant modulator of the nutritional
support of spermatogenesis, being useful to counteract male reproduc-
tive problems associated with hSCs dysfunction.
2. Material and methods
2.1. Chemicals
Dulbecco's Modified Eagle Medium (DMEM), Ham's F-12 (F12) and
Fetal Bovine Serum (FBS): Biochrom (Leonorenstr, Berlin, Germany);
M-PER Mammalian Protein Extraction Reagent and LDH Enzymatic
Assay Kit: Thermo Scientific (Waltham, MA, USA); JC1: Molecular
Probes (Eugene, OR, USA); EGCG (CAS Number 989-51-5): Sigma-
Aldrich (St. Louis, MO, USA); Extracellular O2 Consumption assay:
Abcam (Cambridge, UK); All other chemicals: Sigma-Aldrich (St. Louis,
MO, USA) unless specifically stated.
2.2. Human Sertoli cell primary culture
Testicular tissue processing was performed at Centre for Reproduc-
tive Genetics Professor Alberto Barros (Porto, Portugal) according to
local, national, and European ethical committees' guidelines and the
Declaration of Helsinki. Six testicular biopsies were obtained from six
different patientswith conserved spermatogenesis, after informedwrit-
ten consent. hSCs were obtained from the cells left in tissue culture
plates after each patient's treatment and isolated by our routinemethod
(Oliveira et al., 2009). Cells from each individual were plated separately
in six cell + culture flasks (Sarstedt, Nümbrecht, Germany) and incu-
bated at 33–34 °C to mimic the temperature to which hSCs are subject-
ed in vivo into the scrotum (Ivell, 2007). Moreover, a controlled
atmosphere of 5% CO2 was maintained in the incubator, since it is re-
quired to stabilize the pH of the growth media. After 96 h, cultures
were examined by phase contrast microscopy and only hSCs with con-
taminants below 5% were used. hSCs culture purity was determined as
previously described (Alves et al., 2012).
2.3. Experimental groups
hSCs were allowed growing until reaching 90–95% of confluence.
Subsequently, the culture media were replaced by serum-free media
(DMEM:F12) supplemented with insulin–transferrin–sodium selenite
(ITS)media (10 μg/mL–5.5 μg/mL–0.005 μg/mL, respectively). Three ex-
perimental groups were defined: a control group without EGCG and
two groups supplemented either with 5 or 50 μM of EGCG. Although
the bioavailability of EGCG after drinking tea is very low (0.3–0.5 μM)
(Yang et al., 2009), the ingestion of 400–1200mgof EGCG from a tea ex-
tract (fasting conditions) may result in plasma levels of 2–7 μM (Chow
et al., 2003). Based on these studies, we have selected the lowest con-
centration of 5 μM of EGCG. Furthermore, since many studies reported
the pharmacological relevance of EGCG at 50 μM (Albrecht et al.,
2008; Weber et al., 2004), we have also included this concentration in
our study. After 24 h of treatment with 0, 5 or 50 μM of EGCG, cells
and the respective culture media were collected. Cell viability was eval-
uated by the Trypan Blue Exclusion test and averaged 85–90%.
2.4. Sulforhodamine B assay
A sulforhodamine B (SRB) colorimetric assay was performed as pre-
viously described (Fricker, 1994), to evaluate hSCs proliferative re-
sponses to the culture media (Dias et al., 2015a). In brief, hSCs were
plated in a 96-well culture plate (same amount of cells per well), left
to grow until reaching a confluence of 60–70% and treated with thetest culture media containing 0, 5 or 50 μM of EGCG for 24 h. Then,
cells were fixed overnight (at −20 °C) with a mixture containing 1%
acetic acid and 99% methanol and subsequently stained with 0.05%
(w/v) SRB dissolved in 1% acetic acid for 1 h.Unbound SRBwas removed
by washingwith 1% acetic acid, whereas the bound SRBwas solubilized
with 10mMTris base (pH 10) in a shaker for 10min. A blankwasmade
with Tris base (pH 10) and the absorbance was read at 492 nm. Absor-
bance readings of SRB-stained cells gives a direct measure of cell num-
bers. To obtain concentration–response curves we defined the cell
growth of the control group as 100% and calculated the cell growth of
treated groups relative to control.
2.5. Proton NMR (1H-NMR) spectroscopy
1H-NMR spectra of hSCs extracellular culture media were acquired
and quantified as described by our team (Alves et al., 2011). Sodium fu-
marate (final concentration of 1 mM) was used as an internal reference
(6.50 ppm) to quantify the followingmetabolites present in hSCs extra-
cellular media (multiplet, ppm): lactate (doublet, 1.33); alanine (dou-
blet, 1.45), acetate (singlet, 1.90), pyruvate (singlet, 2.35), citrate
(multiplet, 2.57–2.72) and H1-α-glucose (doublet, 5.22). Relative
areas of 1H-NMR resonances and metabolites concentrations were
quantified as described (Alves et al., 2011).
2.6. Western blot
Total proteins from hSCs were isolated using M-PER Mammalian
Protein Extraction Reagent according to manufacturer's instructions.
Western blot was performed as previously described (Dias et al.,
2013). In brief, proteins were fractionated in 12% polyacrylamide gels,
then the separated proteins were transferred to previously activated
polyvinylidene difluoride (PVDF) membranes and blocked for 90 min
with a 5% non-fat milk solution at room temperature. Afterwards, the
membraneswere incubated overnight at 4 °Cwith the primary antibod-
ies listed in Table 1. Mouse anti-β-actin was used as the protein loading
control. The immunoreactive proteins were detected separately and vi-
sualized after incubation with the respective secondary antibodies
(Table 1) for 90 min, at room temperature. The band density attained
was divided by the corresponding β-actin band intensities and
expressed in fold variation (induction/reduction) relative to the control
group.
2.7. Lactate dehydrogenase (LDH) enzymatic assay
Intracellular LDH activity levels of hSCswere spectrophotometrically
determined using the LDH Enzymatic Assay Kit as described (Dias et al.,
2015b). Absorbance at 490 nmwasmeasured using anAnthos 2010mi-
croplate reader (Biochrom, Berlin, Germany). LDH enzymatic activities
were calculated as units per milligram of protein, using the molar ex-
tinction factor (ε) and expressed as fold variation to the control group.
2.8. Mitochondrial membrane potential
Thefluorescent probe JC1was used tomeasuremitochondrialmem-
brane potential of hSCs, using a slightly modified version of themethod
described by Salvioli et al. (1997). The accumulation of the JC1 dye in
mitochondria depends on mitochondrial membrane potential. In brief,
hSCs were cultured in a 96-well culture plate (same amount of cells
per well) with DMEM:F12 (1:1, pH 7.4) supplemented with 1% FBS.
Cells were left to grow until reach 60–70% of confluence. Then, the cul-
ture medium was replaced by ITS medium supplemented with 0, 5 or
50 μM of EGCG. After 24 h, the medium was removed and cells were
washed with PBS. 100 μL of JC1 staining solution (1 μg/mL), previously
prepared in DMEM:F12 supplemented with 1% FBS, were added to
each well and cells were incubated for 15 min at 37 °C. Afterwards,
cells were washed with PBS and 100 μL of DMEM:F12 supplemented
Table 1
List of the primary and secondary antibodies used in this study.
Antibody Source kDa Dilution Vendor Catalog #
GLUT1 Rabbit 55 1:200 Santa Cruz Biotechnology Heidelberg, Germany sc-7903
GLUT2 Rabbit 60–62 1:5000 Santa Cruz Biotechnology Heidelberg, Germany sc-9117
GLUT3 Goat 48–70 1:200 Santa Cruz Biotechnology Heidelberg, Germany sc-7582
PFK1 Rabbit 85 1:500 Santa Cruz Biotechnology Heidelberg, Germany sc-67028
MCT4 Rabbit 43 1:1000 Santa Cruz Biotechnology Heidelberg, Germany sc-50329
LDH Rabbit 37–38 1:10,000 Abcam Cambridge, MA, USA ab52488
β-Actin Mouse 42 1:5000 Thermo Scientific Waltham, MA, USA MA5-15739
DNP Rabbit – 1:5000 Sigma-Aldrich St. Louis, MO, USA D9656
Nitro-tyrosine Rabbit – 1:5000 Cell Signaling Technology Leiden, Netherlands 9691
4-HNE Goat – 1:5000 Merck Millipore Temecula, USA AB5605
Total OXPHOS cocktail Mouse CI-20 CII-30 CIII-48 CIV-40 CV-55 1:1000 MitoSciences Eugene, Oregon, USA ab110413
Mouse Goat – 1:5000 Sigma-Aldrich St. Louis, MO, USA A3562
Rabbit Goat – 1:5000 Sigma-Aldrich St. Louis, MO, USA A3687
Goat Rabbit – 1:5000 Sigma-Aldrich St. Louis, MO, USA A4187
GLUT1: glucose transporter 1; GLUT2: glucose transporter 2; GLUT3: glucose transporter 3; PFK1: phosphofructokinase 1; MCT4: monocarboxylate transporter 4; LDH: lactate dehydro-
genase; DNP: 2,4-dinitrophenyl hydrazone; 4-HNE: 4-hydroxynonenal; CI: NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 8 (NDUFB8); CII: succinate dehydrogenase
complex, subunit B, iron sulfur (SDHB); CIII: ubiquinol-cytochrome c reductase coreprotein II (UQCRC2); CIV:mitochondrially encoded cytochrome c oxidase I (MTCO1); CV: ATP synthase
alpha-subunit (ATP5A).
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alyzed immediately using a Cytation™ 3 Cell ImagingMulti-ModeRead-
er (BioTek, Winooski, USA) pre-heated at 37 °C. Cells with functional
mitochondria exhibited JC1 aggregates that were detected at 550/
590 nm(excitation/emission), while cellswith dysfunctionalmitochon-
dria mainly exhibited JC1 monomers detected at 485/535 nm (excita-
tion/emission). The JC1 ratio aggregates/monomers was calculated for
each condition as a measure of mitochondrial functionality.2.9. Extracellular oxygen consumption assay
Oxygen consumption is one of themost informative and directmea-
sures of mitochondrial function. We used the extracellular oxygen con-
sumption assay kit (ab197243; Abcam, Cambridge, UK), according to
the manufacturer's instructions, to measure the respiration of hSCs
after exposure to EGCG. Briefly, hSCs were cultured in a 96-well culture
plate with DMEM:F12 (1:1, pH 7.4) supplemented with 10% FBS. Cells
were left to grow until reach 80–90% of confluence. Then, the medium
was replaced by ITS medium supplemented with 0, 5 or 50 μM of
EGCG. After 24 h of exposure, the medium was removed and replaced
by freshly prepared ITS medium. 10 μL of Extracellular O2 consumption
reagent were added to each well, except to the blank control. 2 drops of
high-sensitivity mineral oil (pre-heated at 37 °C) were added to each
well to limit back diffusion of ambient oxygen. Fluorescence intensities
were analyzed immediately using a Cytation™ 3 Cell Imaging Multi-
Mode Reader (BioTek,Winooski, USA) pre-heated at 37 °C. Extracellular
oxygen consumption of hSCs was measured at 1.5 min intervals for
120 min at excitation/emission = 380/650 nm. Cells respiration leads
to oxygen depletion from the surrounding environment, resulting in
the increase in fluorescence signal. Fluorescence intensities were nor-
malized to the blank and expressed as counts per second (CPS) versus
time (min).Fig. 1. Effect of epigallocatechin-3-gallate (5 and 50 μM) in the proliferation of human
Sertoli cells (hSCs). The figure shows pooled data of independent experiments. hSCs
growth is presented as percentage and control value was set at 100%. Results are
expressed as mean ± SEM (n = 6 for each condition). Significantly different results
(P b 0.05) are indicated as: a – relative to control.2.10. Analysis of carbonyl groups, nitration and lipid peroxidation
Carbonyl groups, nitration and lipid peroxidation are usually used as
biomarkers for oxidation and can be evaluated by measuring its
resulting products, 2,4-dinitrophenyl (DNP), nitro-tyrosine and 4-
hydroxynonenal (4-HNE), respectively. The content of these adducts
in hSCs after exposure to EGCG was evaluated using specific antibodies
(Table 1) by slot-blot as previously described (Dias et al., 2015b;
Oliveira et al., 2015b). Results were expressed as fold variation to the
control group.2.11. Statistical analysis
Statistical significance was assessed by one-way ANOVA, followed
by Dunn post-test using GraphPad Prism 6 (GraphPad Software, San
Diego, CA, USA). All data are presented as mean± SEM (N= 6). Differ-
ences with p b 0.05 were considered statistically significant.3. Results
3.1. Exposure to the highest dose of EGCG (50 μM) decreased hSCs
proliferation
We have evaluated hSCs proliferation after exposure to the sever-
al doses of EGCG by the SRB assay. Our results demonstrated that ad-
dition of 5 μMof EGCG to hSCs culture medium slightly decreased the
cell growth to 77 ± 15% comparative to control group (100 ± 16%)
(Fig. 1). Additionally, the group of hSCs exposed to 50 μM of EGCG
presented a cell proliferation of 34 ± 11%, illustrating a significant
decrease to almost one-third of that observed in the control group
(Fig. 1). Based on these results, all the subsequent results were nor-
malized for the total number of cells or amount of protein in each
sample.
Table 2
Metabolites consumption/production and lactate/alanine ratio in human Sertoli cells from
the control group and groups exposed to 5 or 50 μMof epigallocatechin-3-gallate (EGCG).
Metabolites (pmol/μg protein) Control 5 μM of EGCG 50 μM of EGCG
Glucose consumption 49.1 ± 16 47 ± 13 161 ± 47a,b
Pyruvate consumption 3.28 ± 0.36 4.09 ± 0.40 6.25 ± 0.82a
Lactate production 43.26 ± 1.43 51.12 ± 6.70 49.69 ± 4.78
Alanine production 3.13 ± 0.29 3.74 ± 0.65 1.79 ± 0.50a,b
Acetate production 5.08 ± 0.43 6.55 ± 1.38 5.07 ± 0.53
Citrate production 10.15 ± 0.85 10.43 ± 1.33 9.40 ± 0.56
Lactate/alanine ratio 10.42 ± 0.57 10.98 ± 0.36 23.26 ± 0.78a,b
Results are expressed as mean ± SEM (n = 6 for each condition). Significantly different
results (P b 0.05) are indicated as: a – relative to control; b – relative to 5 μM of EGCG.
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EGCG, though GLUT2 protein levels decreased
We have firstly evaluated glucose uptake since it is the main meta-
bolic substrate of cultured hSCs. Our results showed a glucose consump-
tion of 49 ± 16 and 47 ± 13 pmol/μg protein in non-exposed hSCs and
those exposed to 5 μM of EGCG, respectively (Table 2). Contrastingly,
therewas an increase in glucose consumption to 161±47pmol/μg pro-
tein in hSCs exposed to 50 μM of EGCG, relative to cells from the other
experimental groups (Table 2). Glucose transport through the hSCs cy-
toplasmic membrane is mediated by glucose transporters (GLUTs), par-
ticularly GLUT1, GLUT2 and GLUT3 (Oliveira et al., 2012). In our
experimental conditions, we observed that neither the protein levels
of GLUT1 nor GLUT3 (Fig. 2A) were altered in hSCs after exposure to
EGCG. However, there was a decrease in GLUT2 protein levels in hSCs
exposed to 50 μMof EGCG (0.56±0.13 fold variation to the control) rel-
ative to non-exposed hSCs and those exposed to 5 μM of EGCG (1.15 ±
0.13 fold variation to the control) (Fig. 2A).3.3. Exposure of hSCs to 50 μM of EGCG stimulated pyruvate consumption
Once glucose enters the cell, a cascade of reactions involving the en-
zyme phosphofructokinase 1 (PFK1), leads to the conversion of glucose
to pyruvate (Martins et al., 2013). For that reason, we evaluated PFK1
protein levels, as well as pyruvate consumption by hSCs exposed to
EGCG. Concerning PFK1 protein levels, no differences were found be-
tween the experimental groups (Fig. 3A). However, pyruvate consump-
tion increased from 3.28± 0.36 pmol/μg protein in the control group to
6.25 ± 0.82 pmol/μg protein by hSCs exposed to 50 μM of EGCG
(Table 2). Exposure of hSCs to 5 μMof EGCG led to a pyruvate consump-
tion of 4.09 ± 0.40 pmol/μg protein, which was not significantly differ-
ent relative to control (Table 2).Fig. 2. Effect of epigallocatechin-3-gallate (5 and 50 μM) in glucosemetabolism of human Sertoli
transporters (GLUT1, GLUT2 and GLUT3) protein levels (Panel A). Panel B displays the repres
presented as fold variation to the control. Results are expressed as mean ± SEM (n = 6 for
control; b – relative to 5 μM EGCG.3.4. Exposure of hSCs to 50 μM of EGCG decreased LDH and MCT4 protein
levels, as well as LDH activity
In hSCs, most of the pyruvate produced is converted to lactate by
LDH (Dias et al., 2014b) and then exported to the intratubular fluid by
the monocarboxylate transporter 4 (MCT4) (Galardo et al., 2007). Our
results demonstrated a decrease in LDH protein levels in hSCs exposed
to 50 μM of EGCG (0.56 ± 0.03 fold variation to the control) relative
to hSCs from the control group and exposed to 5 μM of EGCG (1.08 ±
0.13 fold variation to the control) (Fig. 3A). In addition, LDH activity of
hSCs exposed to 5 μMof EGCGwas 0.91±0.11 fold variation to the con-
trol, a similar value to cells from the control group (Fig. 3A). Therewas a
decrease in LDH activity of hSCs after exposure to 50 μM of EGCG
(0.06±0.02 fold variation to the control) in comparison to the other ex-
perimental groups (Fig. 3A). Moreover, exposure of hSCs to this dose
also led to decreased protein levels of MCT4 (0.67 ± 0.05 fold variation
to the control) comparative to cells from the control group and those
exposed to 5 μM of EGCG (1.05 ± 0.07 fold variation to the control)
(Fig. 3A). Despite, hSCs lactate production was not affected by exposure
to EGCG (Table 2).
3.5. Alanine production was decreased in hSCs exposed to 50 μM of EGCG
Besides being converted to lactate, pyruvate can also be converted to
alanine (Kaiser et al., 2005) or it can enter themitochondria to originate
acetyl-CoA (Dias et al., 2014b). Subsequently, acetyl-CoA can lead to cit-
rate (Costello and Franklin, 2006) and/or acetate production
(Yamashita et al., 2006). Our results showed that EGCG did not alter ac-
etate nor citrate production by hSCs (Table 2). However, alanine pro-
duction in hSCs exposed to 50 μM of EGCG was decreased (1.79 ±
0.50 pmol/μg protein), relative to the control group (3.13± 0.29 pmol/-
μg protein) and hSCs exposed to 5 μM of EGCG (3.74 ± 0.65 pmol/μg
protein) (Table 2). We also evaluated the ratio lactate/alanine, which
is an index of cellular redox state (Oliveira et al., 2012). hSCs exposed
to 50 μM of EGCG presented an increased lactate/alanine ratio
(23.3 ± 0.8) when compared to the control group (10.4 ± 0.6) and
hSCs exposed to 5 μM of EGCG (11.0 ± 0.4).
3.6. Mitochondrial membrane potential was decreased in hSCs exposed to
50 μM of EGCG
Mitochondrial electron transport chain (ETC) is one of the main cel-
lular generators of ROS. ETC includes four multi-subunit complexes
(complexes I–IV), responsible for oxidative phosphorylation (Turrens,
2003). The electron transport generates an electrochemical proton gra-
dient across the inner mitochondrial membrane, measured as mito-
chondrial membrane potential, which drives ATP synthesis bycells (hSCs). The figure shows pooled data of independent experiments, indicating glucose
entative blots (of one sample) of GLUT1, GLUT2 and GLUT3. Variation in protein levels is
each condition). Significantly different results (P b 0.05) are indicated as: a – relative to
Fig. 3. Effect of epigallocatechin-3-gallate (5 and 50 μM) in pyruvate and lactate metabolism of human Sertoli cells (hSCs). The figure shows pooled data of independent experiments,
indicating phosphofructokinase 1 (PFK1) protein levels, lactate dehydrogenase (LDH) protein levels and activity, as well as monocarboxylate transporter 4 (MCT4) protein levels
(Panel A). Panel B displays the representative blots (of one sample) of PFK1, LDH and MCT4. Variation in protein levels is presented as fold variation to the control. Results are
expressed as mean ± SEM (n = 6 for each condition). Significantly different results (P b 0.05) are indicated as: a – relative to control; b – relative to 5 μM EGCG.
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terations in the protein levels of mitochondrial complexes I–V in hSCs
exposed to EGCG (Table 3). However, JC1 ratio decreased after hSCs ex-
posure to the highest dose of EGCG (50 μM) (1.05 ± 0.07) relative to
control group (1.85 ± 0.14) and hSCs exposed to 5 μM of EGCG
(1.80±0.27) (Fig. 4A), showing a decrease inmitochondrialmembrane
potential in cells exposed to the highest dose of EGCG. Nevertheless, ox-
ygen consumption was similar among the hSCs from the several exper-
imental groups (Fig. 4B).
3.7. Exposure of hSCs to 50 μM of EGCG decreased protein and lipid
oxidation
As high metabolic rates and mitochondrial activity are usually asso-
ciated with ROS overproduction (Aitken et al., 2010) and EGCG is
known for its antioxidant properties (Lombardo et al., 2011), we evalu-
ated its effects against oxidative damages in hSCs. We quantified the
formation of end-products resultant fromprotein oxidation or nitration,
as well as lipid peroxidation when cells were exposed to 5 or 50 μM of
EGCG. Our data showed decreased levels of carbonyl groups and nitra-
tion in hSCs exposed to 50 μM of EGCG (0.86 ± 0.04 and 0.80 ± 0.01
fold variation to the control, respectively) relative to cells exposed to
5 μMof EGCG (1.12± 0.10 and 1.08± 0.10 fold variation to the control,
respectively) (Fig. 5). Exposure of hSCs to 50 μMof EGCG also led to de-
creased levels of lipid peroxidation (0.85 ± 0.04 fold variation to theTable 3
Protein expression levels ofmitochondrial complexes in human Sertoli cells from the con-
trol group and groups exposed to 5 or 50 μM of epigallocatechin-3-gallate (EGCG).
Mitochondrial complexes Control 5 μM of EGCG 50 μM of EGCG
CI 1.00 ± 0.01 1.05 ± 0.10 1.16 ± 0.15
CII 1.00 ± 0.01 1.05 ± 0.09 1.09 ± 0.12
CIII 1.00 ± 0.01 0.95 ± 0.03 1.00 ± 0.08
CIV 1.00 ± 0.02 1.15 ± 0.07 0.98 ± 0.09
CV 1.00 ± 0.02 0.98 ± 0.07 0.97 ± 0.06
CI: NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 8 (NDUFB8); CII: suc-
cinate dehydrogenase complex, subunit B, iron sulfur (SDHB); CIII: ubiquinol-cytochrome
c reductase core protein II (UQCRC2); CIV:mitochondrially encoded cytochrome c oxidase
I (MTCO1); CV: ATP synthase alpha-subunit (ATP5A). Results are expressed as mean ±
SEM (fold variation to the control), n = 6 for each condition.control) comparatively to hSCs from the control group and those ex-
posed to 5 μM of EGCG (1.06 ± 0.02 fold variation to the control)
(Fig. 5).4. Discussion
Oxidative damage to cells and biomolecules has been associated
with the pathology of several diseases/dysfunctions, includingmale fer-
tility (Makker et al., 2009). SCs are essential for the successful progres-
sion of spermatogenesis since they provide all the metabolic needs to
the developing germ cells (Martins et al., 2013). Modulation of SCs me-
tabolism is essential for spermatogenesis (Rato et al., 2012). Thus, mod-
ulators of SCs metabolism can be valuable to counteract male
subfertility/infertility in some conditions, and tea constituents have
shown promising results (Dias et al., 2015b; Martins et al., 2014). Stud-
ies focused on the role of EGCG inmale fertility are scarce andmostly fo-
cused on its effects on sperm quality (De Amicis et al., 2012; Dias et al.,
2016a). Sincemale fertility capacity is highly dependent on hSCsmetab-
olism, we evaluated the effects of EGCG on those mechanisms. Despite
the intricate limitations of the in vitro-in vivo data extrapolations
concerning metabolism, we consider that our in vitro model possesses
the most important features of SCs in vivo and that the data obtained
would be a further step in understanding the effects of EGCG on SCs
physiology and function (Reis et al., 2015).
EGCG can be orally consumed in food supplements prepared from
very concentrated tea extracts or in infusions (diluted). Although the
bioavailability of EGCG after drinking tea is very low (0.3–0.5 μM)
(Yang et al., 2009), the ingestion of 400–1200mgof EGCG from a tea ex-
tract (fasting conditions) may result in plasma levels of 2–7 μM (Chow
et al., 2003). Thus, we selected 5 μM as the lowest concentration of
EGCG in the study. As there are several studies reporting a pharmaco-
logically relevant action of 50 μM of EGCG (Albrecht et al., 2008;
Weber et al., 2004), we also evaluated the effects of that concentration
as well. The main objective of investigating the effects of this
supraphysiologic dose of EGCG is its possible usage in a specific treat-
ment for male reproductive dysfunctions. We choose to expose hSCs
to EGCG for 24 h to mimic a chronic, prolonged and repetitive dose of
EGCG in a short-time.
Fig. 4. Effect of epigallocatechin-3-gallate (5 and 50 μM) in mitochondrial membrane potential and extracellular oxygen consumption of human Sertoli cells (hSCs). The figure shows
pooled data of independent experiments, indicating JC1 ratio (Panel A) and extracellular oxygen consumption (Panel B). Results of JC1 are presented as a ratio aggregates/monomers
while oxygen consumption is presented as fluorescence intensity in CPS (counts per second). Results are expressed as mean ± SEM (n = 6 for each condition). Significantly different
results (P b 0.05) are indicated as: a – relative to control; b – relative to 5 μM EGCG.
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et al., 2004), particularly its ability to act as a potent inhibitor of cell pro-
liferation (Kang, 2015). Previous studies have evidenced significant
metabolic similarities between hSCs and cancer cells (for review
(Oliveira et al., 2015a)). Still, studies from our research group have re-
ported that the intensive glycolytic activity of hSCs is not always correlat-
ed with the proliferative properties of these cells (Dias et al., 2015a; Jesus
et al., 2015; Martins et al., 2015), as frequently happens with cancer cells
(for review (Oliveira et al., 2015a)). The results here presented demon-
strated a dose-dependent decrease of hSCs proliferation when exposedto 5 and 50 μM of EGCG, evidencing a clear anti-proliferative effect of
this compound on these testicular cells. This scenario might also be a re-
sult from EGCG cytotoxicity to hSCs. The exposure of hSCs to 50 μM of
EGCG during 24 h might overcome the maximum tolerable dose, thus
exerting toxicity to hSCs, which results in the observed decrease in hSCs
proliferation. However, some caution should be takenwhenextrapolating
these results to an in vivo situation due to the differences in the proliferat-
ing ability of Sertoli cells in vitro and in vivo (Reis et al., 2015).
EGCG has been ascribed as modulator of cells metabolism, including
spermatozoa (De Amicis et al., 2012). To investigate the effects of EGCG
Fig. 5. Effect of epigallocatechin-3-gallate (5 and 50 μM) in oxidative damage levels of
human Sertoli cells (hSCs). The figure shows pooled data of independent experiments,
indicating carbonyl levels, protein nitration and lipid peroxidation. Results are presented
as fold variation to control. Results are expressed as mean ± SEM (n = 6 for each
condition). Significantly different results (P b 0.05) are indicated as: a – relative to
control; b – relative to 5 μM EGCG.
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colytic pathway, since glucose is themainmetabolic substrate of cultured
hSCs and lactate is the key substrate produced by hSCs for developing
germ cells (Rato et al., 2012). Exposure of hSCs to the highest concentra-
tion of EGCG (50 μM) increased glucose consumption by these cells. No-
tably, a similar effect induced by 40 μM of EGCG was reported in muscle
cells (Zhang et al., 2010). In hSCs, glucose uptake is mediated by GLUT1,
GLUT2 and GLUT3 (Oliveira et al., 2012).We have not detected any alter-
ation in GLUT1 or GLUT3 protein levels. Though, there was a decrease in
GLUT2 levels in hSCs exposed to 50 μMof EGCG. This suggests that the in-
creased glucose uptake observed was sustained by GLUT1 and GLUT3,
which are described to have a higher affinity for glucose than GLUT2,
allowing cells to withstand a high rate of glucose transport (Wood and
Trayhurn, 2003). Since GLUT2 presents a high Michaelis constant (Km),
its rate of glucose uptake decreases in parallel with the decrease of glu-
cose concentration under the physiological range (Eny et al., 2008).
Thus, the decrease in GLUT2 protein levels, can be a result of an adaptive
response to the decrease in glucose concentration related to the consume
of glucose present in the culture media (Macheda et al., 2005).
Once inside the cell, glucose is readily converted to pyruvate, in a
process involving a rate-limiting step mediated by PFK1, which is a con-
trol point of the glycolytic pathway (Rato et al., 2013). The protein levels
of this enzyme in hSCswere not altered by exposure to EGCG, suggesting
that pyruvate production is not compromised. In hSCs, the greatmajority
of pyruvate is transformed in lactate, by LDH (Dias et al., 2014b), and then
transported to the extracellular compartment by MCT4, where it can be
used by developing germ cells (Martins et al., 2013). Exposure of hSCs
to 50 μM of EGCG led to a decrease in LDH protein levels and activity,
and also to decreased MCT4 protein levels. Nevertheless, no differences
were found in lactate production by hSCs exposed to this concentration
of EGCGwhen comparedwith the other conditions. These results suggest
that as lactate is being produced in normal amounts, LDH and MCT4
protein and/or enzyme activity levels are not rate limiting.
The maintenance of lactate production at control levels by hSCs ex-
posed to 50 μMof EGCG is essentially due to the differences in pyruvate
metabolism. Besides the higher pyruvate consumption, we also verified
a decrease in alanine production in these cells. Since alanine is attained
from pyruvate in a reversible reaction catalyzed by alanine transami-
nase (Miyashita et al., 2007) and its production is decreased in hSCs ex-
posed to EGCG (50 μM), our results suggest that the higher pyruvate
consumption is also responsible for themaintenance of the normal pro-
duction of lactate. This scenario resulted in the increase of the lactate/al-
anine ratio in those cells. Lactate/alanine ratio is linked to the
intracellular redox status, since it reflects the NAD+/NADH ratio,
which in turn is directly implicated in energymetabolism. It constitutesa metabolic node well suited for integration of energy metabolism and
an optimal NAD+/NADH ratio is essential for normal mitochondrial
function (Alves et al., 2013).
The maintenance of pyruvate production by the glycolytic pathway
under certain levels is also crucial to maintain a proper mitochondrial
function, since it enters the mitochondria to be converted in acetyl-
CoA (Kim, 1997). Then, acetyl-CoA can then enter the Krebs cycle,
where it is converted to citrate (Costello and Franklin, 2006), or it can
be exported to the cytosol and form acetate (Yamashita et al., 2006),
which can be used for fatty acids and cholesterol synthesis (Shimazu
et al., 2010). When there is a Krebs cycle truncation, citrate can also be
transported to the cytosol or to extracellular compartment (Costello
and Franklin, 2006). Since no alterations were found either in acetate
or citrate extracellular production by hSCs after exposure to EGCG, we
can suggest that pyruvate is not only being used to sustain lactate pro-
duction, but also to fuel the Krebs cycle. These results support that the
functionality of hSCs Krebs cycle is not being compromised by exposure
to EGCG. The normal oxygen consumption among the experimental
groups corroborates our data. In fact, if oxygen consumption was in-
creased, oxidative metabolism should be occurring towards CO2 pro-
duction. Since oxygen consumption was not affected by exposure to
EGCG and neither acetate nor citrate are being exported to the extracel-
lular compartment, these two metabolites should be used for storage
into lipid synthesis within the cytosol. Thismay be part of the additional
nutritional support of spermatogenesis. However, we detected a de-
crease in mitochondrial membrane potential of hSCs exposed to
50 μM of EGCG. The same result was observed in a previous study
where hepatocytes were exposed to 30 μM of EGCG (Kucera et al.,
2015). Still, no differenceswere found in the protein levels ofmitochon-
drial complexes I–V, which are responsible for oxidative phosphoryla-
tion (OXPHOS) and ATP synthesis (Turrens, 2003). Despite protein
levels of mitochondrial complexes were not altered, EGCG may have
some inhibitory effects on the activity of those complexes, as it was pre-
viously described (Valenti et al., 2013; Zheng and Ramirez, 2000). This
may result in a mitochondrial uncoupling, as reported before (Lee and
Kim, 2009), which may also be related to the cytotoxic effect of this
dose. Although Krebs cycle homeostasis is not being compromised by
exposure of hSCs to EGCG, we observed a dissipation of the mitochon-
drial potential, which might be associated with a reprogramming of
the cellular metabolic pathways to sustain hSCs substrate requirements
(Samudio et al., 2009). On the other hand, it is known that OXPHOS in
mitochondria involves ROS production (Turrens, 2003) and it has
been reported that EGCG can be accumulated inmitochondriamodulat-
ing OS (Schroeder et al., 2009). In fact, there was a decrease in protein
oxidation and nitration, as well as in lipid peroxidation in hSCs exposed
to 50 μM of EGCG. This corroborates the protective role attributed to
high doses of EGCG against ROS overproduction (Schroeder et al.,
2009). Hence, EGCG seems to have a dual effect in hSCs mitochondrial
function: while it decreases hSCsmitochondrial functioning, it also pro-
tects hSCs from ROS-induced damages due to its potent antioxidant
potential.
5. Conclusions
Our study demonstrates a dose-dependent modulating action of
EGCG in hSCs metabolism, mitochondrial functionality and oxidative
profile. EGCG at high concentration (50 μM) could modulate hSCs me-
tabolism, maintaining lactate production and Krebs cycle functionality.
Despite 50 μMof EGCGmight decrease ETC function, Krebs cycle process
was preserved. Additionally, our data suggest that citrate and acetate
are being used for storage into lipid synthesis within the cytosol,
which might be part of an additional nutritional support for spermato-
genesis. Moreover, 50 μM of EGCGwas able to decrease oxidative dam-
age to proteins and lipids, which may be of extreme importance in the
improvement of spermatogenesis and male fertility, since oxidative
stress is on the basis of several fertility problems (Agarwal et al.,
221T.R. Dias et al. / Toxicology in Vitro 41 (2017) 214–2222008). The strong enhancement of glucose uptake verified in hSCs ex-
posed to EGCG supports previously reported benefits of EGCG against
DiabetesMellitus (Chen et al., 2009; Ortsater et al., 2012),which is char-
acterized by glucose intolerance (Rato et al., 2015) and strongly affects
hSCs function (Dias et al., 2014b). Although the dose of 50 μM of EGCG
might not be physiological attained by ingestion of EGCG-rich products,
it could be attained with a local administration, supplements or certain
medications. Thus, the main objective using this supraphysiologic dose
was indeed to test the possible usage of EGCG in a specific treatment
for male reproductive dysfunctions. Besides, the bioavailability of
EGCG to Sertoli cells in vivo should be further investigated. Herein,
EGCG is proposed as a novel modulator of cultured hSCs metabolic
and oxidative profiles, which may have important effects in the nutri-
tional support of spermatogenesis, particularly under unfavorable con-
ditions, such as those evidenced by men with metabolic diseases.
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